400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Membrane Transporter/Ion Channel / SGLT / 埃格列净
CAS No.: 1210344-57-2
Synonyms: PF-04971729;PF-4971729;PF-04971729-00
PF-04971729 is a selective sodium-dependent glucose cotransporter (SGLT) inhibitor which selectively targets SGLT2.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT01958671 | - | - | Completed | - | - |
NCT01999218 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT02630706 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
实验方案
技术信息
CAS号 | 1210344-57-2 | 储存条件 |
|
|||||||
分子式 | C22H25ClO7 | 运输 | 蓝冰 | |||||||
分子量 | 436.88 | 别名 | PF-04971729;PF-4971729;PF-04971729-00;Steglatro;埃格列净 | |||||||
溶解度 |
|
动物实验配方 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT01958671 | - | - | Completed | - | - |
NCT01999218 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT02630706 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT02630706 | - | - | Completed | - | - |
NCT02099110 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT01958671 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT01986881 | Type 2 Diabetes Mellitus | Phase 3 | Active, not recruiting | September 11, 2019 | - |
NCT02099110 | - | - | Completed | - | - |
NCT02036515 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT01127308 | Type 2 Diabetes Mellitus (T2DM... more >>) Collapse << | Phase 1 | Completed | - | - |
NCT01999218 | - | - | Completed | - | - |
NCT01986855 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT01096667 | Diabetes Mellitus, Type 2 ... more >> Hypertension Collapse << | Phase 2 | Completed | - | - |
NCT01986855 | - | - | Completed | - | - |
NCT01054300 | Diabetes Mellitus, Type 2 ... more >> Adult Collapse << | Phase 1 | Completed | - | - |
NCT01114568 | Healthy | Phase 1 | Completed | - | - |
NCT01223339 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | - |
NCT01054300 | - | - | Completed | - | - |
NCT00989079 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | - |
NCT02226003 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT02115347 | - | - | Completed | - | - |
NCT02115347 | Type 2 Diabetes Mellitus ... more >> Hepatic Impairment Collapse << | Phase 1 | Completed | - | - |
NCT02036515 | - | - | Completed | - | - |
NCT01018823 | Healthy Volunteer | Phase 1 | Completed | - | - |
NCT02226003 | - | - | Completed | - | - |
NCT01059825 | - | - | Completed | - | - |
NCT01059825 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | - |
NCT01096667 | - | - | Completed | - | - |
靶点 | Description | IC50 |
---|
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网